Insights from the Most-often Searched Drugs by RxSS Members
Drug search trends in the RxSS member portal revealed members are seeking resources to make informed decisions about their prescription ...
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
Biosimilars 101: What They Are, and Why They Matter
Board Certified Biologic and Biosimilars Specialist, Brittany Ulrich, PharmD, CSP, BCBBS breaks down the basics ...
Drug Trends and Shifting Landscapes in 2025 and Beyond
Our panel of frontline RxSS Roundtable experts weighs in on key issues for payers and ...
Navigating Pharmacy’s Future: Strategies for 2025
Listen to the conversation on the evolving pharmacy landscape for 2025 with Eileen Murphy, Director ...
Medicare Star Changes Invite Continued Innovation Amid Economic Headwinds
The latest Medicare Star changes require plan sponsors to maintain focus when it comes to ...
Pharmacist Roots Run Deep and Spread Beyond the Counter at RxSS
RxSS pharmacists may work on our products, support sales, help clients achieve their goals, or ...
Pharmacy Transparency an Option for Medicare Part D Plan Sponsors Amid Market Shake-ups, Financial Pressures
Big changes are coming for Medicare Part D plan sponsors and enrollees. Learn where key ...
Top 5 Things Employers Want from Pharmacy Benefits
As pharmacy costs continue to rise, hear what EHIR members at the top employers said ...
Let’s Recap – 3 Takeaways from My Talk with Select Health’s Chief Pharmacy Benefits Officer
Learn how utilizing the right technology and member engagement strategies can help patients and plans ...
What to Make of the GLP-1 Coverage and Cost Landscape
How are payers handling the rise of GLP-1s? Cost and clinical transparency can support whatever ...
Stay COnnected
Share your email and once a month we’llsend you industry news and insights.
